Gynotech

Company Overview

Snapshot

Founded in June 2016 by Abraham Nissenkorn, Gynotech operates with 1–10 employees. The company is currently in a pre-funding stage, focusing on developing its core medical device technology.

Business overview

Gynotech develops GynoPess, a smart vaginal ring pessary designed to treat and prevent female urinary incontinence and uterine prolapse. This dynamic electromechanical ring incorporates built-in sensors that detect physiological changes and adjust the device's diameter in real-time. GynoPess aims to provide efficient support to relevant organs and continuously records intra-abdominal pressure data to facilitate personalized uro-gynecological treatment. The company operates within the Health Tech & Life Sciences sector, specifically targeting the medical devices and digital healthcare markets, with a focus on women's health in geomarkets such as the United States and Japan.

Company Intelligence Q&A

What is Gynotech's primary product?

Gynotech's primary product is GynoPess, a smart vaginal ring pessary designed for the treatment and prevention of female urinary incontinence and uterine prolapse.

When was Gynotech founded?

Gynotech was founded in June 2016.

Who is a founder of Gynotech?

Abraham Nissenkorn is a founder and CMO of Gynotech.

What is the current operational status of Gynotech?

Gynotech is currently non-active and ceased to operate in July 2022.

Which markets does Gynotech target with its products?

Gynotech targets geomarkets including the United States and Japan with its medical device products.